Over the last 10 years, the Panomics Division of Affymetrix (Panomics) has successfully developed products for drug discovery, drug development, and clinical research utilizing branched DNA (bDNA) technology. These products include single and multiplex DNA and RNA detection assays compatible with cells,FFPE tissues, and tissue lysates.. Affymetrix has licensed bDNA from Siemens Healthcare Diagnostic who utilize bDNA in the IVD-approved Versant assays for HCV and HIV viral load testing.
Recently, Siemens Healthcare Diagnostics and Affymetrix expanded their license agreement for bDNA establishing Affymetrix as the exclusive licensee for in situ applications, including use in the development in vitro assays. This expanded license grants Affymetrix rights to develop and sell QuantiGene ViewRNA products for RNA FISH and CISH assays for both research and clinical applications.
QuantiGene ViewRNA technology is being leveraged in multiple exciting ways to expand the utility of RNA CISH and FISH for biomarker discovery and validation.
- A research collaboration with Massachusetts General Hospital to validate and develop new oncology biomarker tests Read more
- A worldwide collaboration with Leica Microsystems on automated, a single-copy RNA in situ hybridization (ISH) tissue assays Read more
- Partnership with Flagship Biosciences to integrate a suite of histopathology algorithms to deliver image analysis of QuantiGene ViewRNA tissue assays Read More
- The worldwide distribution of ScreenCell circulating tumor cell capture technology Read more